GlassScriptPhysician profile
Philip D Carey
NPI 1366435984
$3,178.40
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,761 · 2020: $376 · 2021: $11.56 · 2023: $29.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $29.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $29.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $897.95 | 2019-2021 | |
| Glaxosmithkline, LLC. | $568.29 | 2019-2023 | Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $472.99 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $257.11 | 2019 | |
| Mylan Specialty L.P. | $168.85 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $145.49 | 2019 | |
| Mallinckrodt Enterprises LLC | $129.15 | 2019 | |
| Genzyme Corporation | $116.06 | 2019-2020 | |
| Insmed, INC. | $80.99 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $64.67 | 2019-2020 | |
| Shire North American Group INC | $46.37 | 2019 | |
| Grifols USA, LLC | $38.79 | 2019 | |
| Arbor Pharmaceuticals, INC. | $25.90 | 2019 | |
| Harmony Biosciences LLC | $19.49 | 2020 | |
| Alexion Pharmaceuticals, INC. | $18.95 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $18.31 | 2019 | |
| Philips North America LLC | $17.85 | 2020 | |
| Novartis Pharmaceuticals Corporation | $15.46 | 2019 | |
| Circassia INC. | $14.53 | 2019 | |
| Resmed Corp | $14.34 | 2020 | |
| Advanced Respiratory, INC | $12.53 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $12.28 | 2019 | |
| Merck Sharp & Dohme LLC | $11.42 | 2019 | |
| Sanofi-Aventis U.S. LLC | $10.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Carey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.